Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Risk Assessment of Ethylhexyl Dimethyl PABA in Cosmetics

  • Sung, Chi Rim (Department of Bio Health Science, College of Natural Science, Changwon National University) ;
  • Kim, Kyu-Bong (College of Pharmacy, Dankook University) ;
  • Lee, Joo Young (BK21Plus Team, College of Pharmacy, The Catholic University of Korea) ;
  • Lee, Byung-Mu (College of Pharmacy, Sungkyunkwan University) ;
  • Kwack, Seung Jun (Department of Bio Health Science, College of Natural Science, Changwon National University)
  • Received : 2019.02.21
  • Accepted : 2019.03.10
  • Published : 2019.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Ethylhexyl dimethyl para-aminobenzoic acid (PABA) is an oily yellow liquid derivative of water-soluble PABA commonly used in sunscreen. Ethylhexyl dimethyl PABA is widely used as an ingredient in many cosmetics at an average concentration of 1.25% (0.5-2.0%) in Korea. Previous studies, including those involving animals, have demonstrated that ethylhexyl dimethyl PABA is toxic to the following four organs: testis, epididymis, spleen, and liver. In addition, experiments using human keratinocytes found that ethylhexyl dimethyl PABA inhibits cell growth and DNA synthesis at low concentrations, and halted the cell cycle of MM96L cells (human melanoma cell line) at the G1 phase. Despite limited clinical data in humans, many studies have confirmed increased mutagenicity of ethylhexyl dimethyl PABA following exposure to sunlight, which suggests that this molecule is likely to contribute to onset of sun-induced cancer despite protecting the skin through absorption of UVB. For risk assessment, the no observed adverse effect level (NOAEL) chosen was 100 mg/kg bw/day in a 4 weeks oral toxicity study. Systemic exposure dosage (SED) was 0.588 mg/kg bw/day for maximum use of ethylhexyl dimethyl PABA in cosmetics. Based on the risk assessment and exposure scenarios conducted in this study, the margin of safety (MOS) was calculated to be 180.18 for a sunscreen containing 8% ethylhexyl dimethyl PABA, which is the maximum level allowed by the relevant domestic authorities.

Keywords

References

  1. DeSimone, E.M., 2nd. (1994) FDA proposes changes in sunscreen regulations. Am. Pharm., 34, 26-31. https://doi.org/10.1016/S0160-3450(15)30396-2
  2. HSDB (2011) Hazardous Substances Data Bank. Available from: https://toxnet.nlm.nih.gov/newtoxnet/hsdb.htm/.
  3. TOXNET (2018) Toxicology Data Network. Available from:https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/.
  4. SCC (1999) Scientific Committee on Cosmetology, Reports of the Scientific Committeeon Cosmetology (9th series), Office for Official Publications of the European Communities, ISBN 92-828-8951-3, 1-1008.
  5. NTP (2001) National Toxicology Program, Nominations in Review 2001.
  6. Erol, M., Cok, L., BostanGayret, O., Gunes, P., Yigit, O., Sayman, E., Gunes, A., Celik, D.S., Hamilcikan, S., Altinay, S. and Ercan, O. (2017) Evaluation of the endocrinedisrupting effects of homosalate (HMS) and 2-ethylhexyl 4-dimethylaminobenzoate(OD-PABA) in rat pups during the prenatal, lactation, and early postnatal periods. Toxicol. Ind. Health, 33, 775-791. https://doi.org/10.1177/0748233717718974
  7. Sigma-Aldrich (2018) MSDS Search and Product Safety Center. Available from: https://www.sigmaaldrich.com/korea/safety-center-korea.html/.
  8. Funk, J.O., Dromgoole, S.H. and Maibach, H.I. (1995) Sunscreen intolerance. Contactsensitization, photocontact sensitization, and irritancy of sunscreen agents. Dermatol. Clin., 13, 473-481. https://doi.org/10.1016/s0733-8635(18)30094-9
  9. Morgan, T.M., Reed, B.L. and Finnin, B.C. (1998) Enhanced skin permeation of sexhormones with novel topical spray vehicles. J. Pharm. Sci., 87,1213-1218. https://doi.org/10.1021/js980025k
  10. Knowland, J., McKenzie, E.A., McHugh, P.J. and Cridland, N.A. (1993) Sunlight-induced mutagenicity of a common sunscreen ingredient. FEBS Lett., 324, 309-313. https://doi.org/10.1016/0014-5793(93)80141-G
  11. Kenney, G.E., Sakr, A., Lichtin, J.L., Chou, H. and Bronaughh, R.L. (1995) In vitro skinabsorption and metabolism of Padimate-O and a nitrosamine formed in Padimate-Ocontaining cosmetic products. J. Soc. Cosmet. Chem., 46, 117-127.
  12. Xu, C. and Parsons, P.G. (1999) Cell cycle delay, mitochondrial stress and uptake ofhydrophobic cations induced by sunscreens in cultured human cells. Photochem. Photobiol., 69, 611-616. https://doi.org/10.1111/j.1751-1097.1999.tb03336.x
  13. Gulston, M. and Knowland, J. (1999) Illumination of human keratinocytes in thepresence of the sunscreen ingredient Padimate-O and through an SPF-15 sunscreenreduces direct photodamage to DNA but increases strand breaks. Mutat. Res., 444, 49-60. https://doi.org/10.1016/S1383-5718(99)00091-1
  14. Federal Register (1999) Federal Register. Rules and Regulations. Vol. 64, No. 98, 27671.
  15. MFDS (2013) Ministry of Food and Drug Safety. MFDS Guidelines on Safety Risk Assessment of Cosmetic Products.